Development and Implementation of a Tobacco and ENDS Use Intervention for Adolescents and Young Adults in the Pediatric Hospital
Overview
- Phase
- Not Applicable
- Intervention
- Control
- Conditions
- Vaping
- Sponsor
- Children's Mercy Hospital Kansas City
- Enrollment
- 144
- Locations
- 1
- Primary Endpoint
- Self-reported 30-day Abstinence
- Status
- Completed
- Last Updated
- 2 months ago
Overview
Brief Summary
The purpose of this study is to develop and evaluate an evidence-based intervention to assist adolescents and young adults with current vaping to quit vaping and smoking.
Detailed Description
Use of electronic nicotine delivery system (ENDS), which are noncombustible tobacco products (e.g., e-cigarettes), has increased dramatically among youth and is associated with numerous adverse health outcomes as well as use of alcohol and other illicit substances. National guidelines recommend counseling to address tobacco use at every adolescent clinical visit; however, many at-risk adolescents do not routinely attend primary care. Although evidence supports treatment of tobacco use during an adult hospitalization, no interventions have been developed or tested in the pediatric hospital setting. Based on promising theoretically-based evidence from the primary care and hospital settings, we will design, iteratively refine and assess implementation of a novel tobacco and ENDS use intervention for hospitalized adolescents and young adults (AYAs). We do so by conducting a randomized controlled pilot study (n=144) with 3-month follow up to evaluate preliminary efficacy as well as implementation outcomes (i.e., acceptability, feasibility, fidelity).
Investigators
Abbey Masonbrink
Pediatric Hospitalist, MD MPH
Children's Hospital Los Angeles
Eligibility Criteria
Inclusion Criteria
- •Admitted to the hospital
- •Screens positive for past 30 day e-cigarette use
- •Parent/guardian agrees to leave the room
Exclusion Criteria
- •Age is less than 14 years or over 21 years
- •Not comfortable speaking/reading English
- •Too ill to participate
- •Severe psychiatric illness
- •Too developmentally delayed/cognitively impaired
Arms & Interventions
Control
Participants will complete the baseline survey and receive an informational brochure
Intervention
Participants will complete the baseline survey, receive a behavioral health intervention supported by computerized decision support, and take an exit survey
Intervention: E-cigarette & Tobacco Use Treatment Intervention
Outcomes
Primary Outcomes
Self-reported 30-day Abstinence
Time Frame: 3 month follow-up
Self reported cessation, assessed at 3 month follow up survey.
Biochemically Verification of Past 30 Day Cessation
Time Frame: 3 month follow-up
For participants who self-reported past 30 day cessation, an option was provided to biochemically verify cessation with a mailed saliva sample.
Secondary Outcomes
- Acceptability of Intervention - Satisfaction and Likeliness to Recommend Program(Study completion (approximately 12 weeks))
- Acceptability of Intervention - Utility of Intervention(Study completion (approximately 12 weeks))
- Feasibility of Intervention - Duration of Intervention(Study completion (approximately 12 weeks))
- Feasibility of Intervention - Intervention Interruptions(Study completion (approximately 12 weeks))
- Feasibility of Intervention - Health Educator Survey(Study completion (approximately 12 weeks))
- Fidelity of Intervention Delivered by a Health Educator(Study completion (approximately 12 weeks))